Month: December 2024

Naeem-Ul-Haq Khan | Radiopharmaceuticals | Best Researcher Award

Published on by WSA Awards

Dr. Naeem-Ul-Haq Khan | Radiopharmaceuticals | Best Researcher Award

Assistant Professor at Government College University Faisalabad, Pakistan

Dr. Naeem-Ul-Haq Khan is a dedicated researcher and academic specializing in Chemistry, with a focus on Radiopharmaceuticals. He holds a Ph.D. from GC University Faisalabad, Pakistan, and the University of Melbourne, Australia, where his research addressed radionuclide-labeled probes for diagnosing and treating malignant diseases. With a blend of academic and research expertise, Dr. Khan has contributed significantly to healthcare advancements. His professional journey includes roles as a researcher, postdoctoral fellow, and project leader, showcasing his ability to secure competitive funding and lead impactful studies. Dr. Khan has authored multiple peer-reviewed articles in renowned journals, presented his work at international conferences, and participated in technical workshops, underlining his commitment to continuous learning and research excellence.

Professional Profile

Education

Dr. Naeem-Ul-Haq Khan has an impressive academic background. He completed his Ph.D. in Chemistry, specializing in Radiopharmaceuticals, from GC University Faisalabad and the University of Melbourne in 2020. His dissertation focused on developing radionuclide-labeled probes for cancer diagnosis and therapy. He earned his M.Phil. in Chemistry from the University of Agriculture Faisalabad in 2013 and a Master’s in Chemistry from the University of Gujrat in 2009, both with first-division honors. Dr. Khan also holds a Bachelor’s degree from Punjab University, Lahore, and earlier academic certifications in Physics, Chemistry, and Mathematics with exceptional results. His consistent academic performance underscores his dedication to excellence in education.

Professional Experience

Dr. Khan’s professional career is marked by impactful roles in academia and research. He is currently a researcher in the Department of Chemistry at GC University Faisalabad. He served as a postdoctoral fellow at the National Institute for Biotechnology and Genetic Engineering (NIBGE), where he contributed to radiopharmaceutical innovation. Previously, he worked on a national project at the Pakistan Institute of Nuclear Science and Technology (PINSTECH), focusing on 177Lu-labeled kits for medical applications. Earlier in his career, he served as a College Teaching Intern, enhancing his teaching and mentoring skills. Dr. Khan’s professional journey showcases a blend of research innovation and academic contributions.

Research Interests

Dr. Khan’s research interests lie in the innovative field of radiopharmaceuticals. He focuses on developing radionuclide-labeled compounds for the early diagnosis and treatment of diseases, particularly cancer and drug-resistant infections. His work integrates chemistry, biotechnology, and medical imaging, reflecting his commitment to advancing healthcare solutions. Dr. Khan is also interested in the biological evaluation of radiolabeled molecules, the development of novel diagnostic tools, and exploring advanced oxidation processes. His interdisciplinary approach enables the translation of fundamental chemistry into impactful biomedical applications.

Research Skills

Dr. Khan possesses extensive research skills, including radiopharmaceutical synthesis, radionuclide labeling, and biological evaluations. His expertise encompasses modern analytical techniques, such as spectroscopy, chromatography, and imaging tools, to investigate radiolabeled compounds. He is skilled in designing and conducting advanced experiments in chemistry and biotechnology, with proficiency in handling radioactive materials. Additionally, Dr. Khan is experienced in scientific writing, data analysis, and technical presentations. His participation in workshops on research paper writing and analytical methods demonstrates his commitment to refining his research capabilities.

Awards and Honors

Dr. Naeem-Ul-Haq Khan has earned several prestigious awards and honors throughout his career. He was awarded the IRSIP scholarship by the Higher Education Commission (HEC) of Pakistan for advanced research at the University of Melbourne and Peter MacCallum Cancer Centre. He also secured a PKRs. 2.7 million research grant from the National Institute of Health, Islamabad, to develop radiopharmaceuticals for diagnosing infections caused by resistant pathogens. These achievements highlight his ability to attract competitive funding and contribute to cutting-edge research. His academic and research accomplishments have positioned him as a recognized leader in radiopharmaceutical innovation.

Conclusion

Dr. Naeem-Ul-Haq Khan demonstrates exceptional research abilities and a solid track record in radiopharmaceuticals and chemistry. His academic background, research publications, and funding success make him a strong candidate for the Best Researcher Award. To enhance his candidacy further, focusing on citation impact, innovation, and leadership roles in the research community would be beneficial. Overall, Dr. Khan is a deserving nominee with significant contributions to both fundamental and applied sciences. 🌟

Publication Top Notes

  • Decolorization of basic turquoise blue X-GB and basic blue X-GRRL by the Fenton’s process and its kinetics
    Authors: NUH Khan, HN Bhatti, M Iqbal, A Nazir
    Published in: Zeitschrift für Physikalische Chemie 233 (3), 361-373
    Year: 2019
    Citations: 73
  • Antioxidants: Natural antibiotics
    Authors: SAR Naqvi, S Nadeem, S Komal, SAA Naqvi, MS Mubarik, SY Qureshi, et al.
    Published in: Antioxidants
    Year: 2019
    Citations: 48
  • Kinetic study of degradation of basic turquoise blue X-GB and basic blue X-GRRL using advanced oxidation process
    Authors: NUH Khan, HN Bhatti, M Iqbal, A Nazir, H Ain
    Published in: Zeitschrift für Physikalische Chemie 234 (11-12), 1803-1817
    Year: 2020
    Citations: 21
  • Assessment of the nutritional status of bottle-fed infants and the prevalence of infections, allergy, and diarrhea among bottle-fed infants and its comparison with exclusively …
    Authors: Z Hussain, N Khan
    Published in: J Pediatr Neonatal Care 6 (4), 00249
    Year: 2017
    Citations: 14
  • Technetium-99m labeled Ibuprofen: Development and biological evaluation using sterile inflammation induced animal models
    Authors: NUH Khan, SAR Naqvi, H Sohail, S Roohi, MA Jamal
    Published in: Molecular Biology Reports 46, 3093-3100
    Year: 2019
    Citations: 11
  • Technetium‐99m radiolabeling and biological study of epirubicin for in vivo imaging of multi‐drug‐resistant Staphylococcus aureus infections via single photon …
    Authors: NUH Khan, SAR Naqvi, S Roohi, TA Sherazi, ZA Khan, AF Zahoor
    Published in: Chemical Biology & Drug Design 93 (2), 154-162
    Year: 2019
    Citations: 11
  • Development of an efficient callus-derived regeneration system for garlic (Allium sativum L.) from root explant
    Authors: N Khan, MF Chaudhary, AM Abbasi, SA Khan, A Nazir, GM Shah
    Published in: Journal of Plant Breeding and Agriculture 1 (1), 1-12
    Year: 2017
    Citations: 10
  • The role of ethrel in plant growth and development under different environmental conditions
    Authors: M Bhat, M Mir, N Khan, NA Lonr, KA Bhat, SM Razui, S Hayat, WA Payne, et al.
    Published in: International Journal of Current Research 4, 4-13
    Year: 2010
    Citations: 7
  • Facile one-step synthesis of gold nanoparticles using Viscum album and evaluation of their antibacterial potential
    Authors: M Ishaq, M Numan, U Zeb, F Cui, S Shad, SA Hayat, A Azizullah, I Uddin, et al.
    Published in: Functional Plant Biology 50 (11), 955-964
    Year: 2023
    Citations: 3
  • Enzymatic degradation study of 111 In-labeled minigastrin peptides using cathepsin B enzyme and AR42J cancer cell line for the development of neuroendocrine tumor imaging …
    Authors: SAR Naqvi, M Yameen, Z Hussain, S Asim, M Usman, NUH Khan, et al.
    Published in: Pakistan Journal of Pharmaceutical Sciences 31 (6 Suppl), 2585-2589
    Year: 2018
    Citations: 3

Mohammadkian Zarafshani | Medicine and Dentistry | Best Researcher Award

Published on by WSA Awards

Dr. Mohammadkian Zarafshani | Medicine and Dentistry | Best Researcher Award

Rheumatology at Tehran University of Medical Sciences, Iran

Dr. Mohammadkian Zarafshani is a dedicated physician and researcher with a robust foundation in clinical and basic medical sciences. With extensive experience in patient care and research, he has demonstrated excellence in managing projects and publishing findings in esteemed journals and conferences. His work spans multiple fields, including surgery, rheumatology, and oncology, reflecting his versatility and commitment to advancing medical knowledge. As a peer reviewer for several prestigious journals, he contributes significantly to the scientific community by ensuring high-quality research dissemination. His passion for integrating clinical practice with research has led to impactful discoveries, particularly in endoplasmic reticulum stress pathways and their role in colorectal cancer. Dr. Zarafshani is recognized for his effective communication, leadership, and problem-solving skills, which complement his medical expertise.

Professional Profile

Education

Dr. Zarafshani earned his Doctor of Medicine (MD) degree from Kermanshah University of Medical Sciences, Iran, in 2021. His academic journey was marked by a distinguished thesis conducted at the Cancer Biology Research Center, Tehran University of Medical Sciences, focusing on the XBP1s factor as an ER stress pathway indicator in colorectal cancer patients. This research highlighted his ability to bridge clinical observations with molecular insights. His educational achievements, coupled with active participation in conferences and research committees, laid a strong foundation for his ongoing contributions to medical science.

Professional Experience

Dr. Zarafshani serves as a physician and researcher at Bistoon Private Hospital’s Department of Surgery in Kermanshah, Iran, since 2021. His role involves patient care and clinical research, reflecting his ability to blend practical expertise with investigative pursuits. During his military service from 2021 to 2023, he worked as a physician and researcher at the Rheumatology Research Center, Shariati Hospital, Tehran University of Medical Sciences, conducting impactful studies in rheumatology. His previous engagements include supervising research projects and assisting in studies on colorectal cancer and pediatric Behçet’s disease. Dr. Zarafshani’s career highlights his commitment to clinical excellence and advancing medical research.

Research Interests

Dr. Zarafshani’s research interests encompass surgery, oncology, and rheumatology, with a particular focus on understanding molecular mechanisms underlying diseases. His notable work includes exploring the IRE1/XBP1s pathway in colorectal cancer and investigating genetic factors influencing autoimmune conditions. He is deeply committed to translating basic research into clinical applications, enhancing patient outcomes through innovative therapeutic approaches. Dr. Zarafshani is also intrigued by the psychosocial aspects of healthcare, evident in his studies on communication between students and professors and the mental health benefits of cultural practices like Quran memorization.

Research Skills

Dr. Zarafshani possesses advanced research skills, including clinical data collection, statistical analysis, and laboratory techniques like PCR and immunohistochemistry (IHC). He excels in medical writing and manuscript preparation, contributing as an active journal reviewer for Clinical Case Reports, PLOS One, and the International Journal of Surgery Case Reports. His expertise extends to capillaroscopy and other diagnostic methods, enhancing his capability to conduct comprehensive clinical research. Dr. Zarafshani’s ability to lead multidisciplinary teams and address complex problems underscores his proficiency in collaborative and independent research.

Awards and Honors

Dr. Zarafshani has received numerous accolades for his contributions to medical research and education. He was recognized by the Chairman of Kermanshah University of Medical Sciences for outstanding presentations during Health Week in 2015 and 2016. He earned the Best Paper Award as a panelist at Shahid Beheshti University of Medical Sciences in 2015. Additionally, he was honored as an exceptional researcher by the Vice Chancellor of Kermanshah University of Medical Sciences in 2015. These achievements reflect his dedication to excellence in research, education, and clinical practice.

Conclusion 💡

Dr. Mohammadkian Zarafshani is a highly accomplished researcher with a robust portfolio in clinical and molecular research. His ability to bridge basic and applied research, coupled with strong academic credentials and recognized contributions, makes him a competitive candidate for the Best Researcher Award.

Publication Top Notes

  1. Zarafshani M, Avateffazeli M, Moeini Taba SM, Faghihi R, Beikmohamadi Hezaveh S, Ziaee V, Tahghighi F, Loghman M
    Misdiagnosed for 14 Years: Adenosine deaminase 2 (ADA2) Deficiency in a Teen Mimicking Polyarteritis Nodosa.
    Clinical Case Reports Journal, 2024, November 24.
  2. Zarafshani M, Rahmanian E, Manouchehri Ardekani R, Hassan Matini SA, Loghman M, Faezi ST
    Concomitant manifestations of systemic lupus erythematosus flare-up and nodal marginal zone B-cell lymphoma in a 41-year-old male patient: A challenging case report.
    Clinical Case Reports Journal, 2024, August 19; 12(8):e9337.
  3. Zarafshani M, Mahmoodzadeh H, Soleimani V, Moosavi MA, Rahmati M
    Expression and Clinical Significance of IRE1-XBP1s, p62, and Caspase-3 in Colorectal Cancer Patients.
    Iranian Journal of Medical Sciences, 2024, January 1; 49(1):10-21.
  4. Fattahi MR, Zarafshani M, Abdolahad M, Jalaeefar A, Mahdavi R, Yousefpour N, Saffar H, Mousavi‐Kiasary SM, Pakdel F
    Intraoperative use of electrical impedance spectroscopy for adenoid cystic carcinoma of the lacrimal gland: A case report.
    Clinical Case Reports, 2023, October; 11(10):e7995.
  5. Mozafar M, Mohebbi H, Parvas E, Sakhaei D, Zarafshani M, Ilkhani S
    Superior mesenteric artery thrombosis with concomitant pancreaticoduodenal artery pseudoaneurysm in a 60-year-old male patient—A case report.
    International Journal of Surgery Case Reports, 2023, August 1; 109:108622.
  6. Zarafshani M, Loghman M, Hakemi MS, Nili F, Hezaveh SB, Nejad MT, Faezi ST
    IgM nephropathy in a patient with dermatomyositis following COVID‐19 vaccination: A case report.
    International Journal of Rheumatic Diseases, 2023, July 11.
  7. Zarafshani M, Sharafi L, Athari Z
    The Investigate Students’ Motivation to Communicate Teacher-Students in Kermanshah University of Medical Sciences in 2016-17.
    Education Strategies in Medical Sciences, 2019, March 10; 11(6):1-1.
  8. Zarafshani MK, Shahmohammadi A, Vaisi-Raygani A, Bashiri H, Yari K
    Association of interleukin-8 polymorphism (+781 C/T) with the risk of ovarian cancer.
    Meta Gene, 2018, June 1; 16:165-9.
  9. Zarafshani MK, Rezaee AM, Zarafshani G
    Comparing the indicators of general health among two groups of female Quran memorizers and non-memorizers in Kermanshah, Iran.
    Journal of Research on Religion & Health, 2017, January 1; 3(2):43-52.